SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-053993
Filing Date
2019-10-24
Accepted
2019-10-24 20:42:24
Documents
2
Period of Report
2019-10-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2842
2 POA DOCUMENT poa.txt EX-24.3_876878 4725
  Complete submission text file 0001209191-19-053993.txt   8961
Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39094 | Film No.: 191167289

Mailing Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089
Business Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 650-325-5156
Phathom Pharmaceuticals, Inc. (Issuer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations